Author Response to Comment on: "Benefit-Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study".
Ammar Abdulrahman JairounSabaa Saleh Al-HemyariMoyad ShahwanTariq Al-QirimMonzer ShahwanPublished in: Clinical medicine insights. Endocrinology and diabetes (2024)